Pur­due’s emer­gency opi­oid over­dose treat­ment is ap­proved by the FDA

Pur­due Phar­ma on Wednes­day won FDA ap­proval for its emer­gency treat­ment for opi­oid over­dose as the com­pa­ny at­tempts to dis­tance it­self from its role in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.